Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Get alerts for new trials in your area by subscribing now
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
for
Overweight, Prediabetic State, Prehypertension,
Location: Pelham AL, Birmingham AL, Anniston AL, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07794579
Phase 3, Recruiting
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
for
Neoplasms, Endometrial
Location: Birmingham AL, Omaha NE, Toronto, Montreal
Sponsor: GlaxoSmithKline
Sex: Female
Age: 18+
Code: NCT07286331
Phase 3, Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Birmingham AL, Mobile AL, Owensboro KY, Charleston SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase 3, Recruiting
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
for
Lichen Sclerosus
Location: Birmingham AL, Jacksonville FL, Clearwater FL, Tampa FL,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07335588
Phase 3, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
for
Refractory Angina, Coronary Artery Disease
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Durham NC,
Sponsor: XyloCor Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07048808
Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Atlanta GA, Knoxville TN,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Birmingham AL, Macon GA, North Little Rock AR,
Sponsor: LEO Pharma
Sex: All
Age: 0 - 11
Code: NCT06311682
Phase 3, Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
for
Asthma
Location: Birmingham AL, Albany GA, Owensboro KY, Maryville IL,